Showing results (21-30 of 36) with videos related to
Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 7, 2002
Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibioticsD Rischin, S P Ackland, J Smith, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1993
Pelvic radiotherapy with concurrent 5-fluorouracil modulated by leucovorin for rectal cancer: a phase II studyS G Cooper, A Bonaventura, S P Ackland, et al.Pharmacology & Therapeutics|September 29, 2000
Basis for effective combination cancer chemotherapy with antimetabolitesG J Peters, C L van der Wilt, C J van Moorsel, et al.The Pharmacogenomics Journal|June 10, 2010
Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivoC E de Bock, M B Garg, N Scott, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
Human plasma pharmacokinetics of thiotepa following administration of high-dose thiotepa and cyclophosphamideS P Ackland, K E Choi, M J Ratain, et al.Investigational New Drugs|March 11, 2006
Phase II study of vinflunine in patients with metastatic renal cell carcinomaD Goldstein, S P Ackland, D R Bell, et al.British Journal of Cancer|November 3, 2005
A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancerS P Ackland, M Jones, D Tu, et al.International Journal of Radiation Oncology, Biology, Physics|January 15, 1995
Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution studyJ W Denham, C S Hamilton, D Christie, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational studyS P Ackland, A Anton, G P Breitbach, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 1995
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter studyB H Burmeister, J W Denham, M O'Brien, et al.Pageof 4